Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-02-10

Clinical Trial Update: Celiac Disease and Vitamin Status: Evaluation of the Effect of Supplementation With a Probiotic (VIVOMIXX®) in a Cohoort of Celiac Patients [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating the effect of probiotic VIVOMIXX® supplementation on vitamin status in patients with celiac disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vivomixx (Probiotic formulation)

Snippet

Sponsor: University of Milan | Conditions: Celiac Disease | Phase 4 | Status: UNKNOWN